Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies

Completed

Conditions studied: Down Syndrome, Aneuploidy

In brief

To collect samples for the purpose of developing and optimizing an in vitro noninvasive prenatal diagnostic (NIPD) test. The NIPD test employs circulating cell free (ccff) DNA extracted from whole blood samples collected from women who are pregnant with a fetus previously determined to have a chromosomal abnormality. The NIPD result will be compared to the standard test results obtained from other test methods such as karyotype, FISH, QF-PCR, and/or any commercially available NIPD test.

Key facts

Study ID
NCT01052688
Run by
Sequenom, Inc.
People needed
150
Starts
2009-11-01
Expected to finish
2021-08-31
Last updated by the study team
2021-09-20

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.